- Latest weekly return ranks in the strongest part of its sector group.
NCH2
GER
Week ended 07 Aug 2026
Weekly Investor Report
thyssenkrupp nucera AG & Co. KGaA · Industrials · Specialty Industrial Machinery
Latest close
8.00 EUR
6.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -3.6% below the Trend Line and sits at 19.6% of its 52-week range. The latest completed week returned 6.1%, after a 6.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
30
out of 100
Latest Close
8.00 EUR
7 Aug 2026
1W Return
6.1%
latest completed week
4W Return
6.2%
short-term follow-through
12W Return
-5.7%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
6.1%
Latest completed week; four-week move 6.2%.
Indicator stack
11/37
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.6% below the Trend Line and sits at 19.6% of its 52-week range. The latest completed week returned 6.1%, after a 6.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1612-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.2% over four weeks, -5.7% over 12 weeks, and -19.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.78Latest activity-pressure read.
Pressure change15.1%Four-week change in activity pressure.
Leadership-14.84Latest relative-leadership reading.
RS change17.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 82%
Model confidence 77%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality28/100Profitability and accounting quality. Underlying universe rank 73; rank 1 is best.
Momentum16/100Medium-term price momentum. Underlying universe rank 85; rank 1 is best.
Growth6/100Revenue and earnings growth. Underlying universe rank 95; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 1.8x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -3.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 8.8% Gross profit retained from each unit of revenue.
- Operating margin
- -12.0% Operating profit retained from revenue.
- Free-cash-flow margin
- -1.9% Free cash flow generated from revenue.
- Return on invested capital
- -158.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -2.0% Latest one-year revenue growth.
- EPS growth
- -59.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 14.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 11 relevant articles.
1 positive · 9 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.8%Distance below the 52-week high.
13-week volatility4.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+7.4%Week of 3 Jul.
Worst week-8.4%Week of 26 Jun.
Latest week+6.1%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains8
Flat weeks0
Modest losses9
Sharp losses5
Recent vol4.4%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -3.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Industrials
4-week rank42 / 100
Group average4.0%
Trend breadth49.0%
Trend49.0%active weekly trend signals
MD59.0%positive activity pressure
RS53.0%positive relative leadership
Four-week leaders
IndustryDE Specialty Industrial Machinery
4-week rank12 / 36
Group average1.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD44.4%positive activity pressure
RS38.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.16; No reversal markers Factors20/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 45; Small Cap Core rank 74 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 11 relevant articles.
Is thyssenkrupp nucera KGaA (XTRA:NCH2) Undervalued On Its India Green Hydrogen Deal? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 8.00 EUR | 6.1% | 8.30 EUR | 10.84 EUR | -0.78 | -14.84 | 276.8K | Off |
| 31 Jul 2026 | 7.54 EUR | -0.3% | 8.33 EUR | 10.93 EUR | -0.98 | -18.06 | 245.4K | Off |
| 24 Jul 2026 | 7.57 EUR | 0.6% | 8.38 EUR | 11.03 EUR | -1.00 | -16.58 | 193.0K | Off |
| 17 Jul 2026 | 7.52 EUR | -0.1% | 8.42 EUR | 11.13 EUR | -1.03 | -16.73 | 226.9K | Off |
| 10 Jul 2026 | 7.53 EUR | -1.0% | 8.47 EUR | 11.23 EUR | -0.92 | -17.99 | 274.9K | Off |
| 3 Jul 2026 | 7.61 EUR | 7.4% | 8.47 EUR | 11.33 EUR | -0.76 | -20.04 | 65.9K | Off |
| 26 Jun 2026 | 7.08 EUR | -8.4% | 8.48 EUR | 11.43 EUR | -0.65 | -22.70 | 96.1K | Off |
| 19 Jun 2026 | 7.73 EUR | -3.1% | 8.49 EUR | 11.46 EUR | -0.24 | -17.18 | 105.1K | Off |
| 12 Jun 2026 | 7.98 EUR | -0.7% | 8.50 EUR | 11.48 EUR | -0.03 | -13.70 | 114.5K | Off |
| 5 Jun 2026 | 8.04 EUR | -7.8% | 8.52 EUR | 11.51 EUR | 0.06 | -13.82 | 99.9K | Off |
| 29 May 2026 | 8.72 EUR | 1.2% | 8.53 EUR | 11.53 EUR | 0.08 | -8.26 | 575.0K | Off |
| 22 May 2026 | 8.62 EUR | 1.6% | 8.54 EUR | 11.55 EUR | -0.03 | -8.72 | 729.0K | Off |
| 15 May 2026 | 8.48 EUR | 3.9% | 8.56 EUR | 11.57 EUR | -0.18 | -6.72 | 637.9K | Off |
| 8 May 2026 | 8.17 EUR | -6.4% | 8.65 EUR | 11.59 EUR | -0.32 | -11.67 | 430.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.